Showing 1 - 4 results of 4 for search 'Maite Gorostegui', query time: 0.02s
Refine Results
-
1
Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab by Amalia Varo, Alicia Castañeda, Saray Chamorro, Juan Pablo Muñoz, Maite Gorostegui, Mónica S. Celma, Sandra Lopez, Margarida Simao, Sara Perez-Jaume, Jaume Mora
Published 2023-05-01
Article -
2
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—U... by Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz, Moira Garraus, Cristina Larrosa, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe
Published 2023-04-01
Article -
3
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chanc... by Juan Pablo Muñoz, Cristina Larrosa, Saray Chamorro, Sara Perez-Jaume, Margarida Simao, Nazaret Sanchez-Sierra, Amalia Varo, Maite Gorostegui, Alicia Castañeda, Moira Garraus, Sandra Lopez-Miralles, Jaume Mora
Published 2023-10-01
Article -
4
Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma by Jaume Mora, Alicia Castañeda, Maria Cecilia Colombo, Maite Gorostegui, Fernando Gomez, Salvador Mañe, Vicente Santa-Maria, Moira Garraus, Napoleon Macias, Sara Perez-Jaume, Oscar Muñoz, Juan Pablo Muñoz, Ignasi Barber, Mariona Suñol
Published 2021-03-01
Article